Health Care & Life Sciences » Biotechnology | Kolon Life Science Inc.

Kolon Life Science Inc. | Ownership

Companies that own Kolon Life Science Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
173,955
1.52%
4,066
0%
07/31/2018
BlackRock Fund Advisors
96,280
0.84%
0
0%
09/05/2018
BlackRock Advisors (UK) Ltd.
84,559
0.74%
0
0%
09/06/2018
Dimensional Fund Advisors LP
28,541
0.25%
-607
0%
04/30/2018
Norges Bank Investment Management
23,461
0.21%
17,677
0%
12/31/2017
Mirae Asset Global Investments Co., Ltd.
14,964
0.13%
3,587
0.01%
04/30/2018
Korea Investment Management Co., Ltd.
10,806
0.1%
3,679
0.06%
01/31/2018
RAM Active Investments SA
10,727
0.09%
10,727
0.02%
06/30/2017
Charles Schwab Investment Management, Inc.
7,787
0.07%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
4,534
0.04%
0
0%
03/31/2018

About Kolon Life Science

View Profile
Address
7th Floor, Kolon Tower Annex
Gwacheon-si GY 13837
Korea, Republic Of
Employees -
Website http://www.kolonls.co.kr
Updated 09/14/2018
KOLON Life Science, Inc. engages in the manufacture and sale of pharmaceuticals and environment materials. It operates through the Pharmaceuticals and Environment Businesses. The Pharmaceutical business provides cell and gene therapeutics.